|
TENX Tenax Therapeutics Inc 34956 |
| Income Statement |
|
Net Income
|
tenx_10q
|
3,960,469 |
| Balance Sheet |
|
Current Assets
|
99,783,628 |
|
Assets
|
99,784,745 |
|
Current Liabilities
|
2,561,690 |
|
Liabilities
|
2,561,690 |
|
Equity
|
97,223,055 |
|
Shares Out
|
3,409,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-11,283,967 |
| Market Analysis |
Market Cap
|
13,188,712 |
|
Price
|
6.26 |
|
BVPS
|
28.52 |
|
PB
|
0.23 |
|
EPS
|
-22.35 |
|
PS
|
0.08 |
|
FCF
|
-11,283,967 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TENX documents filed with the SEC.
TENX Filings
Clear
